Trial Profile
AN INVESTIGATOR BLIND PARALLEL GROUP VEHICLE CONTROL STUDY COMPARING THE EFFICACY AND SAFETY OF CD 5024 1% CREAM WITH METRONIDAZOLE 0.75% CREAM IN SUBJECTS WITH PAPULOPUSTULAR ROSACEA OVER 16 WEEKS TREATMENT.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 May 2013
Price :
$35
*
At a glance
- Drugs Ivermectin (Primary) ; Metronidazole
- Indications Bacterial infections; Rosacea
- Focus Therapeutic Use
- 30 Jul 2011 New trial record